• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维钙化性胰腺糖尿病。长期生存分析。

Fibrocalculous pancreatic diabetes. Long-term survival analysis.

作者信息

Mohan V, Premalatha G, Padma A, Chari S T, Pitchumoni C S

机构信息

M.V. Diabetes Specialties Center, Madras, India.

出版信息

Diabetes Care. 1996 Nov;19(11):1274-8. doi: 10.2337/diacare.19.11.1274.

DOI:10.2337/diacare.19.11.1274
PMID:8908394
Abstract

OBJECTIVE

To determine the long-term survival and causes of death in fibrocalculous pancreatic diabetes, a form of diabetes secondary to tropical chronic pancreatitis.

RESEARCH DESIGN AND METHODS

A cohort of 370 patients with fibrocalculous pancreatic diabetes were analyzed with respect to survival time from the date of occurrence of the first symptom of the disease as well as after the onset of diabetes. The cause of death was analyzed in the patients who died. Cumulative survival rates were calculated by the actuarial method, and life table graphs were plotted by mathematical calculations.

RESULTS

Long-term survival of patients with fibrocalculous pancreatic diabetes is much better today than that described 30 years ago. About 80% of patients were alive 35 years after the first episode of abdominal pain. The median survival time after the diagnosis of diabetes was 25 years. These figures, however, are still considerably lower than the life expectancy of the age- and sex-matched general population. Diabetic nephropathy was the main cause of death. Pancreatic cancer and other chronic pancreatitis-related causes as well as malnutrition and infections were also important contributors to mortality.

CONCLUSIONS

The overall prognosis for patients with fibrocalculous pancreatic diabetes appears to have improved possibly because of earlier diagnosis, better management of diabetes, and improved nutrition.

摘要

目的

确定纤维钙化性胰腺糖尿病(一种继发于热带慢性胰腺炎的糖尿病)的长期生存率及死亡原因。

研究设计与方法

对370例纤维钙化性胰腺糖尿病患者进行分析,记录从疾病首发症状出现之日起以及糖尿病发病后的生存时间。对死亡患者的死因进行分析。采用精算方法计算累积生存率,并通过数学计算绘制生命表图。

结果

如今,纤维钙化性胰腺糖尿病患者的长期生存率比30年前描述的情况要好得多。约80%的患者在首次出现腹痛35年后仍存活。糖尿病诊断后的中位生存时间为25年。然而,这些数字仍远低于年龄和性别匹配的普通人群的预期寿命。糖尿病肾病是主要死因。胰腺癌和其他与慢性胰腺炎相关的病因以及营养不良和感染也是导致死亡的重要因素。

结论

纤维钙化性胰腺糖尿病患者的总体预后似乎有所改善,这可能是由于早期诊断、更好的糖尿病管理以及营养状况的改善。

相似文献

1
Fibrocalculous pancreatic diabetes. Long-term survival analysis.纤维钙化性胰腺糖尿病。长期生存分析。
Diabetes Care. 1996 Nov;19(11):1274-8. doi: 10.2337/diacare.19.11.1274.
2
Fibrocalculous pancreatic diabetes in Pune, India. Clinical features and follow-up for 7 yr.印度浦那的纤维钙化性胰腺糖尿病。临床特征及7年随访
Diabetes Care. 1993 Jun;16(6):916-21. doi: 10.2337/diacare.16.6.916.
3
Fibrocalculous pancreatic diabetes in infancy--two case reports.
Diabetes Res Clin Pract. 1994 Sep;25(2):137-40. doi: 10.1016/0168-8227(94)90039-6.
4
Prevalence of fibrocalculous pancreatic diabetes in Chennai in South India.印度南部钦奈地区纤维钙化性胰腺性糖尿病的患病率
JOP. 2008 Jul 10;9(4):489-92.
5
Fibrocalculous pancreatic diabetes in a young Ugandan patient, a rare form of secondary diabetes.一名年轻乌干达患者患纤维钙化性胰腺性糖尿病,这是一种罕见的继发性糖尿病。
BMC Res Notes. 2012 Nov 5;5:622. doi: 10.1186/1756-0500-5-622.
6
Pregnancy in fibrocalculous pancreatic diabetes.纤维钙化性胰腺糖尿病患者的妊娠情况
J Assoc Physicians India. 1991 May;39(5):426-7.
7
Fibrocalculous pancreatic diabetes in the elderly.老年人纤维钙化性胰腺糖尿病
J Assoc Physicians India. 1989 May;37(5):342-4.
8
Fibrocalculous pancreatic diabetes in a child: case report.
East Afr Med J. 1999 Dec;76(12):703-5.
9
Tropical chronic pancreatitis: an update.
J Clin Gastroenterol. 2003 Apr;36(4):337-46. doi: 10.1097/00004836-200304000-00012.
10
Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of Diabetes.热带慢性胰腺炎中的糖尿病并非仅仅是继发性糖尿病类型。
Pancreatology. 2004;4(5):461-7. doi: 10.1159/000079849. Epub 2004 Jul 15.

引用本文的文献

1
Prevalence of End-Organ Damage, Beta Cell Reserve, and Exocrine Pancreas Defect in Fibrocalculous Pancreatic Diabetes: An Eastern India Perspective.纤维钙化性胰腺糖尿病患者的终末器官损害、β细胞储备及外分泌胰腺缺陷的患病率:来自印度东部的观点
Indian J Endocrinol Metab. 2019 Jul-Aug;23(4):438-445. doi: 10.4103/ijem.IJEM_214_19.
2
My 40-year journey in diabetes research: The power of collaboration.我在糖尿病研究领域的40年历程:合作的力量。
Perspect Clin Res. 2018 Jul-Sep;9(3):113-122. doi: 10.4103/picr.PICR_86_18.
3
Fibro-calculous pancreatic diabetes: Changing hues with changing times.
纤维钙化性胰腺性糖尿病:随时代变迁而呈现不同面貌。
Indian J Endocrinol Metab. 2012 Sep;16(5):677-8. doi: 10.4103/2230-8210.100626.
4
Genetic aspects of tropical calcific pancreatitis.热带钙化性胰腺炎的遗传学方面
Rev Endocr Metab Disord. 2008 Sep;9(3):213-26. doi: 10.1007/s11154-008-9088-y.
5
Tropical chronic pancreatitis.热带慢性胰腺炎
Postgrad Med J. 2003 Nov;79(937):606-15. doi: 10.1136/pmj.79.937.606.
6
Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis.口服胰酶疗法对热带钙化性胰腺炎患者糖尿病的控制作用
Int J Pancreatol. 1998 Aug;24(1):19-22. doi: 10.1007/BF02787526.